GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 1,932.00
+1.00 (0.05%)
At close: Apr 9, 2026
GeneMatrix Market Cap
GeneMatrix has a market cap or net worth of 39.4 billion as of April 10, 2026. Its market cap has decreased by -21.30% in one year.
Market Cap
39.40B
Enterprise Value
n/a
Revenue
4.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,932.00
Market Cap Chart
Since November 6, 2009, GeneMatrix's market cap has increased from 33.85B to 39.40B, an increase of 16.40%. That is a compound annual growth rate of 0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 39.40B | -21.30% |
| Dec 30, 2025 | 50.07B | -9.74% |
| Dec 30, 2024 | 55.47B | -12.40% |
| Dec 28, 2023 | 63.32B | -23.43% |
| Dec 29, 2022 | 82.69B | -58.54% |
| Dec 30, 2021 | 199.45B | -62.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 456.71B |
| 3billion | 380.50B |
| GENINUS | 161.74B |
| HLB Panagene | 103.90B |
| Cytogen | 91.82B |
| Green Cross Medical Science | 78.81B |
| Protia | 58.40B |
| Seoulin Bioscience | 53.49B |